ACI submits tox data to FSA

Compliance CBD novel food

The Association for the Cannabinoid Industry (ACI) submitted a complete toxicological package to the Food Standards Agency (FSA) on Friday, 4 November 2022, to support members’ novel food applications. These applications account for 33% of the applications made to the FSA, and align to approximately half of the products identified on the public list. Currently […]

British Cannabis snags Elixinol license

Australian CBD brand, Elixinol, is set to return to the UK market, following a new licensing and distribution agreement with British Cannabis. In 2021, Elixinol announced plans to cease trading in the UK and European Union in order to focus its attention on the US and Australian markets. The company said that decision was down […]